Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

25
DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
25
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Seizures l: Introduction01:20

Seizures l: Introduction

42
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
42
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Western Trauma Association critical decisions in trauma: Lung injury.

The journal of trauma and acute care surgery·2026
Same authorSame journal

The provision of palliative care: A Western Trauma Association critical decisions algorithm.

The journal of trauma and acute care surgery·2026
Same author

Closing the loop: Understanding ostomy reversal rates and risks in trauma patients.

The journal of trauma and acute care surgery·2026
Same author

Diaphragm stimulation after human spinal cord injury: Effects on respiratory function and diaphragm muscle activation.

The journal of trauma and acute care surgery·2026
Same author

Adherence of Impulse Control in Primary Management of Grade I and II Blunt Thoracic Aortic Injury.

The Journal of surgical research·2026
Same author

Characterizing Contemporary Management of Major Pediatric Vascular Trauma: A Multiyear, Dual-Center Retrospective Analysis.

Journal of the American College of Surgeons·2026

Related Experiment Video

Updated: May 4, 2026

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

26.4K

More harm than good: antiseizure prophylaxis after traumatic brain injury does not decrease seizure rates but may

Indermeet S Bhullar1, Donald Johnson, Julia P Paul

  • 1From the Division of Acute Care Surgery (I.S.B., J.P., A.K., E.F.), Division of Pharmacy (D.J.), and Division of Pediatrics (J.J.T.), University of Florida College of Medicine (D.J., J.P., E.F.), Jacksonville, Florida..

The Journal of Trauma and Acute Care Surgery
|December 26, 2013
PubMed
Summary

Phenytoin prophylaxis after traumatic brain injury (TBI) did not prevent early seizures and was associated with worse functional outcomes. Further randomized studies are needed to confirm these findings for blunt TBI.

More Related Videos

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

10.0K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

8.0K

Related Experiment Videos

Last Updated: May 4, 2026

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

26.4K
Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

10.0K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

8.0K

Area of Science:

  • Neuroscience
  • Clinical Neurology
  • Trauma Surgery

Background:

  • Traumatic brain injury (TBI) is a significant cause of mortality and morbidity.
  • Seizures are a common complication following TBI.
  • Current guidelines recommend antiseizure prophylaxis with phenytoin (PP) for the first 7 days post-TBI.

Purpose of the Study:

  • To evaluate the efficacy of phenytoin prophylaxis (PP) in preventing early seizures after blunt severe TBI.
  • To assess the impact of PP on functional recovery at hospital discharge.

Main Methods:

  • Retrospective review of adult patients with blunt severe TBI hospitalized for at least 7 days.
  • Comparison of clinical seizure rates and functional outcomes between patients receiving no prophylaxis (NP) and those receiving PP.
  • Statistical analysis using chi-squared tests.

Main Results:

  • No significant difference in seizure rates between NP and PP groups (2.3% vs. 4%).
  • PP was associated with a significantly longer hospital stay (36 vs. 25 days).
  • PP resulted in significantly worse functional outcomes at discharge (Glasgow Outcome Scale and modified Rankin Scale scores).

Conclusions:

  • Phenytoin prophylaxis may not effectively decrease early posttraumatic seizures.
  • PP may negatively impact functional outcomes following blunt TBI.
  • Results require verification through randomized controlled trials before clinical practice changes; findings do not apply to penetrating trauma.